I see the Infant App will have more technology limitation than Painchek otherwise why wouldn't PCK commercialise into this massive market as it seems like an easy winner??? It was approved for procedural use so I can't see how they can use this for other situation other than during or after procedural use.
- Forums
- ASX - By Stock
- PCK
- Ann: SPP & shareholder update webinar
PCK
painchek ltd
Add to My Watchlist
0.00%
!
3.5¢

Ann: SPP & shareholder update webinar, page-40
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.47M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 759628 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 759628 | 0.035 |
6 | 556450 | 0.034 |
6 | 687303 | 0.033 |
2 | 402500 | 0.032 |
6 | 264958 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 15000 | 1 |
0.035 | 275000 | 4 |
0.037 | 29634 | 1 |
0.038 | 23802 | 2 |
0.040 | 225143 | 2 |
Last trade - 09.43am 18/06/2025 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online